On the ethics of oestrogen treatment for tall girls: an update

2009 ◽  
Vol 35 (11) ◽  
pp. 713-714 ◽  
Author(s):  
P Louhiala
1986 ◽  
Vol 113 (4_Suppl) ◽  
pp. S170-S173 ◽  
Author(s):  
OLAV TRYGSTAD

Abstract In 1980-1985 680 preadolescent tall girls were treated with pharmacological doses of oestrogen to reduce final height. Indications for the therapy were predicted final height >+2.5 SD (180.75 cm), idiopathic scoliosis, and psychosocial problems. Until 1976 141 girls were given diethyl stilboestrol 5 mg daily. By advice of Prader this was then replaced by ethinyl oestradiol and a progestin was given on days 5-10 each month. The mean duration of therapy was close to 2 years. The observed short-term unwanted effects were due to the pharmacological actions of the drugs, (11 girls had galactorrhoea at the end of therapy; no pituitary prolactionoma was observed) or events happening by chance.


The Lancet ◽  
2004 ◽  
Vol 364 (9444) ◽  
pp. 1513-1518 ◽  
Author(s):  
Alison Venn ◽  
Fiona Bruinsma ◽  
George Werther ◽  
Priscilla Pyett ◽  
Donna Baird ◽  
...  

1989 ◽  
Vol 149 (1) ◽  
pp. 14-17 ◽  
Author(s):  
M. Hermanussen ◽  
K. Geiger-Benoit ◽  
J. Burmeister

1994 ◽  
Vol 153 (4) ◽  
pp. 237-240 ◽  
Author(s):  
J. M. Brinkers ◽  
P. J. Lamoré ◽  
E. F. Gevers ◽  
B. Boersma ◽  
J. M. Wit

1991 ◽  
Vol 80 (6-7) ◽  
pp. 712-717 ◽  
Author(s):  
A. IGNATIUS ◽  
H. L. LENKO ◽  
J. PERHEENTUPA

1994 ◽  
Vol 153 (4) ◽  
pp. 237-240 ◽  
Author(s):  
J. M. Brinkers ◽  
P. J. Lamor� ◽  
E. F. Gevers ◽  
B. Boersma ◽  
J. M. Wit

Sign in / Sign up

Export Citation Format

Share Document